Search

Displaying results 891 - 900 of 10000 in total
  1. Indication

    Hypokalemic Periodic Paralysis

    go.drugbank.com/conditions/DBCOND0002204
    Drugs: Diclofenamide
    Synonyms: Periodic paralysis I
  2. Target

    Cag alpha

    go.drugbank.com/bio_entities/BE0002850
    TargetHelicobacter pylori

    Polypeptides: Cag alphaSynonyms: Cag-alfa, cag-alpha
  3. Target

    Cellular retinoic acid-binding protein 1

    go.drugbank.com/bio_entities/BE0000508
    CarrierTransporterTargetHumans

    Cytosolic CRABPs may regulate the access of retinoic acid to the nuclear retinoic acid receptors

    Synonyms: CRABP-I, Cellular retinoic acid-binding protein I
  4. Target

    GTP cyclohydrolase 1

    go.drugbank.com/bio_entities/BE0001055
    TargetEnzymeHumans

    Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function ...

    Synonyms: GTP-CH-I, GTP cyclohydrolase I
  5. Drug

    Apple cider vinegar

    go.drugbank.com/drugs/DB16596
    Investigational

    Mixtures: KORDEL`S CALCIUM & MAGNESIUM PLUS TABLETProducts: Hongdongsam najel-na
  6. Drug

    Combretastatin A4

    go.drugbank.com/drugs/DB14680
    Experimental

    Synonyms: CA4, PHENOL, 2-METHOXY-5-(2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-, (Z)-
  7. Drug

    AB-201

    go.drugbank.com/drugs/DB18629
    Investigational

    AB-201 is a CAR-NK cell therapy targeted against HER2.[L48340] It is under investigation for the treatment of HER2-positive cancers, including breast and gastric carcinomas.

    Synonyms: Ex vivo expanded allogeneic cord blood-derived NK cells that have been genetically modified to express a HER2-directed CAR and secrete IL-15
  8. Drug

    Pramipexole

    go.drugbank.com/drugs/DB00413
    ApprovedInvestigational

    RLS is a sleep-related disorder characterized by unpleasant sensations in the lower extremities, often accompanied by an uncontrollable urge to move the legs [A176876]. … It was first approved by the FDA in 1997 [L5882].

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingSynonyms: (S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
  9. Target

    Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3

    go.drugbank.com/bio_entities/BE0001872
    TargetHumans

    Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins.

    Synonyms: GlcAT-I, GlcUAT-I
  10. Drug

    Enalapril

    go.drugbank.com/drugs/DB00584
    ApprovedInvestigationalVet approved

    Commonly marketed under the trade name Vasotec, enalapril was first approved by the FDA in 1985 for the management of hypertension, heart failure, and asymptomatic left ventricular dysfunction. … Enalapril is an orally-active and long-acting nonsulphydryl antihypertensive agent that suppresses the renin-angiotensin-aldosterone system to lower blood pressure.

    Synonyms: (S)-1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline, 1-(N-((S)-1-carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl esterInternational brands: Vasotec IV